MediWound (MDWD) Competitors

MediWound (NASDAQ:MDWD) and Syndax Pharmaceuticals (NASDAQ:SNDX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability.

Do analysts prefer MDWD or SNDX?

MediWound currently has a consensus target price of $31.80, indicating a potential upside of 54.22%. Syndax Pharmaceuticals has a consensus target price of $35.91, indicating a potential upside of 229.44%. Given Syndax Pharmaceuticals' higher probable upside, analysts clearly believe Syndax Pharmaceuticals is more favorable than MediWound.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Syndax Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.91

Is MDWD or SNDX more profitable?

Syndax Pharmaceuticals has a net margin of 0.00% compared to MediWound's net margin of -142.29%. Syndax Pharmaceuticals' return on equity of -64.34% beat MediWound's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediWound	-142.29%	-82.17%	-33.67%
Syndax Pharmaceuticals	N/A	-64.34%	-57.72%

Does the MarketBeat Community favor MDWD or SNDX?

MediWound received 8 more outperform votes than Syndax Pharmaceuticals when rated by MarketBeat users. However, 65.22% of users gave Syndax Pharmaceuticals an outperform vote while only 62.40% of users gave MediWound an outperform vote.

Company	Underperform	Outperform
MediWound	Outperform Votes 400 62.40%	Underperform Votes 241 37.60%
Syndax Pharmaceuticals	Outperform Votes 392 65.22%	Underperform Votes 209 34.78%

Does the media refer more to MDWD or SNDX?

In the previous week, Syndax Pharmaceuticals had 3 more articles in the media than MediWound. MarketBeat recorded 4 mentions for Syndax Pharmaceuticals and 1 mentions for MediWound. Syndax Pharmaceuticals' average media sentiment score of 1.33 beat MediWound's score of 0.93 indicating that Syndax Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
MediWound	Positive
Syndax Pharmaceuticals	Positive

Which has better valuation & earnings, MDWD or SNDX?

MediWound has higher earnings, but lower revenue than Syndax Pharmaceuticals. MediWound is trading at a lower price-to-earnings ratio than Syndax Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$19.21M	11.60	-$6.72M	-$2.09	-9.87
Syndax Pharmaceuticals	$43.72M	21.45	-$209.36M	-$3.86	-2.82

Do insiders and institutionals believe in MDWD or SNDX?

46.8% of MediWound shares are held by institutional investors. 9.2% of MediWound shares are held by company insiders. Comparatively, 4.1% of Syndax Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more risk & volatility, MDWD or SNDX?

MediWound has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, Syndax Pharmaceuticals has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.

Summary

Syndax Pharmaceuticals beats MediWound on 11 of the 18 factors compared between the two stocks.